The World Health Organisation (WHO) has approved a COVID-19 vaccine made by Sinovac Biotech for emergency use listing.
It's the second Chinese-produced shot to get its endorsement, a WHO statement said on Tuesday.
WHO emergency listing is a signal to national regulators on a product's safety and efficacy.
It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, which currently faces major supply problems.
In a statement, the independent panel of experts said it recommended Sinovac's vaccine for adults over 18, with a second dose 2-4 weeks later.
There was no upper age limit as data suggested it is likely to have a protective effect in older people.
Netanyahu orders deeper Israeli incursion into Lebanon
Ebola recoveries bring signs of hope in DRC as suspected cases emerge outside Africa
Blast in Myanmar village reportedly kills 55 and injures dozens more
US military says it turned away blockade runner trying to reach Iranian port
